Organization
Alpheus Medical
1 clinical trial
Clinical trial
A Phase 1 Multi-center Clinical Trial Evaluating the Safety and Tolerability of 5-aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy(SDT) in Patients With Recurrent High Grade Glioma (HGG)Status: Active (not recruiting), Estimated PCD: 2024-12-31